117 related articles for article (PubMed ID: 37852832)
21. Evolving role of neoadjuvant therapy in rectal cancer.
Schrag D
Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
Kulaylat AS; Hollenbeak CS; Stewart DB
Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695
[TBL] [Abstract][Full Text] [Related]
23. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
24. Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis.
Chen JH; Ye Q; Huang F
BMC Gastroenterol; 2023 Mar; 23(1):83. PubMed ID: 36959560
[TBL] [Abstract][Full Text] [Related]
25. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
26. Analysis of delay in adjuvant chemotherapy in locally advanced rectal cancer.
Farzaneh CA; Pigazzi A; Duong WQ; Carmichael JC; Stamos MJ; Dekhordi-Vakil F; Dayyani F; Zell JA; Jafari MD
Tech Coloproctol; 2023 Jan; 27(1):35-42. PubMed ID: 36042105
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers.
Wang YW; Huang LY; Song CL; Zhuo CH; Shi DB; Cai GX; Xu Y; Cai SJ; Li XX
World J Gastroenterol; 2015 Sep; 21(35):10174-83. PubMed ID: 26401082
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
Ye W; Shi L; Qian L; Sun Y; Sun X
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
[TBL] [Abstract][Full Text] [Related]
29. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
[TBL] [Abstract][Full Text] [Related]
31. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
Wang X; Yin C; Su S; Li X; Wang C; Zhang C; Liu M
BMC Cancer; 2018 Nov; 18(1):1067. PubMed ID: 30400782
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database.
Coffman AR; Tao R; Cohan JN; Huang LC; Pickron TB; Torgeson AM; Lloyd S
J Gastrointest Oncol; 2021 Aug; 12(4):1482-1497. PubMed ID: 34532104
[TBL] [Abstract][Full Text] [Related]
36. Trends and Factors Associated With Receipt of Upfront Surgery for Stage II to III Rectal Adenocarcinoma in the United States, 2006 to 2016.
Hein DM; Ahn C; Aguilera TA; Folkert MR; Sanford NN
Am J Clin Oncol; 2021 May; 44(5):187-194. PubMed ID: 33710137
[TBL] [Abstract][Full Text] [Related]
37. Use of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Rectal Cancer.
Hu KY; Simpson MT; Blank JJ; Szabo A; Eastwood D; Ludwig KA; Peterson CY; Ridolfi TJ
J Surg Res; 2019 Nov; 243():447-452. PubMed ID: 31376796
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
Naffouje SA; Manguso N; Imanirad I; Sahin IH; Xie H; Hoffe S; Frakes J; Sanchez J; Dessureault S; Felder S
J Surg Oncol; 2022 Dec; 126(7):1219-1231. PubMed ID: 35916542
[TBL] [Abstract][Full Text] [Related]
39. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
40. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
